Form 4: Bunge Global SA Director Acquires Additional Shares Through Dividend Feature
SEC Form 4 Filing
Director Eliane Aleixo Lustosa de Andrade acquired 13 shares of Bunge Global SA common stock on September 2, 2024, through a dividend feature of the company's equity incentive plans.
Summary
- On September 2, 2024, Eliane Aleixo Lustosa de Andrade, a director of Bunge Global SA, acquired 13 shares of common stock.
- The acquisition was made through a dividend feature under the company's equity incentive plans.
- The price per share was $100.95.
- Following the transaction, Ms. Lustosa de Andrade directly owns 4,468 shares of Bunge Global SA.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to dividend distribution under existing equity plans. The director's increased stake is mildly positive, suggesting confidence, but it's not a major event.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders, primarily providing transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 09/02/2024 | Date of transaction: Eliane Aleixo Lustosa de Andrade acquired 13 shares of Bunge Global SA common stock. |
| 09/04/2024 | Date of signature: The Form 4 was signed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.